Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2014 1
2015 4
2018 2
2019 5
2020 4
2021 2
2022 3
2023 2
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
Azacitidine Plus Venetoclax for the Treatment of Relapsed and Newly Diagnosed Acute Myeloid Leukemia Patients.
Garciaz S, Hospital MA, Alary AS, Saillard C, Hicheri Y, Mohty B, Rey J, D'Incan E, Charbonnier A, Villetard F, Maisano V, Lombardi L, Ittel A, Mozziconacci MJ, Gelsi-Boyer V, Vey N. Garciaz S, et al. Among authors: maisano v. Cancers (Basel). 2022 Apr 16;14(8):2025. doi: 10.3390/cancers14082025. Cancers (Basel). 2022. PMID: 35454930 Free PMC article.
Vaccination of multiple myeloma: Current strategies and future prospects.
Allegra A, Penna G, Innao V, Greve B, Maisano V, Russo S, Musolino C. Allegra A, et al. Among authors: maisano v. Crit Rev Oncol Hematol. 2015 Nov;96(2):339-54. doi: 10.1016/j.critrevonc.2015.06.003. Epub 2015 Jun 18. Crit Rev Oncol Hematol. 2015. PMID: 26123319 Review.
Reduced post-transplant cyclophosphamide doses in haploidentical hematopoietic cell transplantation for elderly patients with hematological malignancies.
Duléry R, Goudet C, Mannina D, Bianchessi A, Granata A, Harbi S, Maisano V, Chabannon C, Malard F, Brissot E, Sestili S, Banet A, Van de Wyngaert Z, Belhocine R, Ederhy S, Castagna L, Bramanti S, Blaise D, Mohty M, Fürst S, Devillier R. Duléry R, et al. Among authors: maisano v. Bone Marrow Transplant. 2023 Apr;58(4):386-392. doi: 10.1038/s41409-022-01908-y. Epub 2022 Dec 30. Bone Marrow Transplant. 2023. PMID: 36585459
Azacitidine-venetoclax versus azacitidine salvage treatment for primary induction failure or first relapsed acute myeloid leukaemia patients.
Petit C, Saillard C, Mohty B, Hicheri Y, Villetard F, Maisano V, Charbonnier A, Rey J, D'Incan E, Rouzaud C, Gelsi-Boyer V, Murati A, Lhoumeau AC, Ittel A, Mozziconacci MJ, Alary AS, Hospital MA, Vey N, Garciaz S. Petit C, et al. Among authors: maisano v. Eur J Haematol. 2024 Apr;112(4):530-537. doi: 10.1111/ejh.14140. Epub 2023 Nov 29. Eur J Haematol. 2024. PMID: 38031389
Checkpoint inhibition before haploidentical transplantation with posttransplant cyclophosphamide in Hodgkin lymphoma.
De Philippis C, Legrand-Izadifar F, Bramanti S, Giordano L, Montes de Oca C, Duléry R, Bouabdallah R, Granata A, Devillier R, Mariotti J, Sarina B, Harbi S, Maisano V, Furst S, Pagliardini T, Weiller PJ, Lemarie C, Calmels B, Chabannon C, Santoro A, Mohty M, Blaise D, Castagna L. De Philippis C, et al. Among authors: maisano v. Blood Adv. 2020 Apr 14;4(7):1242-1249. doi: 10.1182/bloodadvances.2019001336. Blood Adv. 2020. PMID: 32227210 Free PMC article.
Risk Factors for Early Cytomegalovirus Reactivation and Impact of Early Cytomegalovirus Reactivation on Clinical Outcomes after T Cell-Replete Haploidentical Transplantation with Post-Transplantation Cyclophosphamide.
Mariotti J, Legrand F, Furst S, Giordano L, Magri F, Richiardi L, Granata A, De Philippis C, Maisano V, Faraci D, Sarina B, Giaccone L, Harbi S, Mannina D, Valli V, Tordato F, Mineri R, Bramanti S, Santoro A, Bruno B, Devillier R, Blaise D, Castagna L. Mariotti J, et al. Among authors: maisano v. Transplant Cell Ther. 2022 Mar;28(3):169.e1-169.e9. doi: 10.1016/j.jtct.2021.12.014. Epub 2021 Dec 23. Transplant Cell Ther. 2022. PMID: 34954296 Free article.
Allogeneic stem cell transplantation in poor prognosis peripheral T-cell lymphoma: the impact of different donor type on outcome.
Castagna L, Pagliardini T, Bramanti S, Schiano de Colella JM, Montes de Oca C, Bouabdallah R, Mariotti J, Fürst S, Granata A, De Philippis C, Harbi S, Sarina B, Legrand F, Maisano V, Weiller PJ, Chabannon C, Carlo-Stella C, Santoro A, Blaise D, Devillier R. Castagna L, et al. Among authors: maisano v. Bone Marrow Transplant. 2021 Apr;56(4):883-889. doi: 10.1038/s41409-020-01133-5. Epub 2020 Nov 15. Bone Marrow Transplant. 2021. PMID: 33191403 Free PMC article.
Poor prognosis of SRSF2 gene mutations in patients treated with VEN-AZA for newly diagnosed acute myeloid leukemia.
Berton G, Sedaki B, Collomb E, Benachour S, Loschi M, Mohty B, Saillard C, Hicheri Y, Rouzaud C, Maisano V, Villetard F, Corda ED', Charbonnier A, Rey J, Hospital MA, Ittel A, Abbou N, Fanciullino R, Dadone-Montaudié B, Vey N, Venton G, Cluzeau T, Alary AS, Garciaz S. Berton G, et al. Among authors: maisano v. Leuk Res. 2024 Apr 15;141:107500. doi: 10.1016/j.leukres.2024.107500. Online ahead of print. Leuk Res. 2024. PMID: 38636413 Free article.
Posttransplantation cyclophosphamide vs. antithymocyte globulin as GVHD prophylaxis for mismatched unrelated hematopoietic stem cell transplantation.
Nykolyszyn C, Granata A, Pagliardini T, Castagna L, Harbi S, Bouabdallah R, Vey N, Fürst S, Maisano V, Legrand F, Lemarié C, Calmels B, Chabannon C, Weiller PJ, Blaise D, Devillier R. Nykolyszyn C, et al. Among authors: maisano v. Bone Marrow Transplant. 2020 Feb;55(2):349-355. doi: 10.1038/s41409-019-0682-2. Epub 2019 Sep 18. Bone Marrow Transplant. 2020. PMID: 31534196
20 results